Expression of guanylyl cyclase C mRNA in peripheral blood from patients with colorectal cancers and its significance

宗祥云,师英强,孙孟红,杜祥

DOI: https://doi.org/10.3969/j.issn.1007-3639.2005.04.008

2005-01-01

Abstract:Purpose:To investigate the diagnostic significa nce of detecting guanylyl cyclase C mRNA in peripheral blood in patients with co lorectal cancers, to determine whether GCC is correlated with local recurrence o r metastases of CRCs and to some extent implies micrometastases. Methods:Blood samples from eighty-three patients with colorect al cancers were tested from August to November in 2003. Each sample contained 5 ml peripheral blood from which the total RNAs were extracted. Then GCC mRNA was detected by reverse transcriptase polymerase chain reaction. Forty-seven contro lled cases were tested, too. Results:Within 83 cases with CRCs, fifty-seven samples were fo und to be GCC mRNA positive, the rate was 68.7%. In the controlled group the pos itive rate was 21.3%, the difference between CRCs group and controlled group was significant, P=0.001. Of all 83 cases with CRCs, sixty-nine cases had prim ary tumors and 14 developed recurrent tumors or tumor metastases. Of 69 cases wi th primary CRCs 44 cases were found to be GCC mRNA positive, the rate was 63.8%. Thirteen out of 14 cases with recurrent CRCs or with tumor metastases were foun d to be GCC mRNA positive, the rate was 92.9%. There was significant difference in GCC mRNA positive rates between primary tumors and recurrent tumors. Conclusions:Guanylyl cyclase C were highly expressed in periphe ral blood of patients with colorectal rectal carcinomas, especially in those wit h recurrent tumors or tumor metastases. GCC mRNA should be an indication for ear ly recurrence or metastases of colorectal carcinomas.